News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
36,547 Results
Type
Article (1581)
Company Profile (4)
Press Release (34962)
Section
Business (15151)
Career Advice (90)
Deals (1937)
Drug Delivery (3)
Drug Development (4280)
FDA (1248)
Job Trends (1120)
News (22108)
Policy (1369)
Tag
2027 Genetown Elite (1)
Academia (32)
Accelerated approval (4)
Allergies (30)
Alliances (1335)
ALS (21)
Alzheimer's disease (53)
Antibody-drug conjugate (ADC) (26)
Approvals (1352)
Artificial intelligence (11)
Autoimmune disease (14)
Automation (1)
Bankruptcy (5)
Best Places to Work (1108)
Biosimilars (15)
Biotechnology (3)
Bladder cancer (38)
Brain cancer (4)
Breast cancer (55)
Cancer (372)
Cardiovascular disease (42)
Career advice (82)
CAR-T (6)
Cell therapy (15)
Cervical cancer (3)
Clinical research (4158)
Collaboration (53)
Compensation (21)
Complete response letters (1)
COVID-19 (63)
C-suite (14)
Cystic fibrosis (4)
Data (636)
Depression (16)
Diabetes (32)
Diagnostics (279)
Digital health (4)
Drug discovery (4)
Drug pricing (4)
Duchenne muscular dystrophy (25)
Earnings (14161)
Events (3283)
Executive appointments (14)
FDA (1715)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (35)
Gene editing (3)
Gene therapy (22)
GLP-1 (43)
Government (98)
Guidances (169)
Healthcare (751)
HIV (3)
Huntington's disease (3)
IgA nephropathy (5)
Immunology and inflammation (12)
Immuno-oncology (5)
Indications (17)
Infectious disease (86)
Inflammatory bowel disease (21)
Influenza (12)
Intellectual property (17)
Interviews (7)
IPO (1365)
IRA (1)
Job creations (114)
Job search strategy (78)
JPM (1)
Kidney cancer (2)
Labor market (2)
Layoffs (7)
Legal (222)
Liver cancer (3)
Lung cancer (61)
Lymphoma (58)
Machine learning (2)
Manufacturing (28)
MASH (20)
Medical device (691)
Medtech (696)
Mergers & acquisitions (604)
Metabolic disorders (95)
mRNA (9)
Multiple sclerosis (15)
NASH (1)
Neurodegenerative disease (15)
Neuropsychiatric disorders (7)
Neuroscience (166)
NextGen: Class of 2026 (150)
Non-profit (51)
Now hiring (2)
Obesity (40)
Opinion (2)
Ovarian cancer (10)
Pain (13)
Pancreatic cancer (17)
Parkinson's disease (9)
Partnered (2)
Patents (24)
Patient recruitment (14)
Peanut (6)
People (1095)
Pharmaceutical (1)
Pharmacy benefit managers (2)
Phase 1 (787)
Phase 2 (1294)
Phase 3 (2122)
Pipeline (983)
Policy (4)
Postmarket research (283)
Preclinical (319)
Press Release (1)
Prostate cancer (14)
Psychedelics (1)
Radiopharmaceuticals (13)
Rare diseases (58)
Real estate (154)
Regulatory (1416)
Reports (3)
Research institute (43)
Resumes & cover letters (7)
Rett syndrome (1)
RSV (7)
Schizophrenia (25)
Series A (2)
Series B (1)
Sickle cell disease (5)
Special edition (1)
Spinal muscular atrophy (12)
Sponsored (1)
Startups (73)
Supply chain (6)
Tariffs (2)
The Weekly (1)
Vaccines (44)
Weight loss (20)
Women's health (9)
Date
Today (8)
Last 7 days (56)
Last 30 days (291)
Last 365 days (2437)
2026 (418)
2025 (2425)
2024 (2448)
2023 (2752)
2022 (3478)
2021 (3044)
2020 (2478)
2019 (1794)
2018 (1500)
2017 (1260)
2016 (908)
2015 (1081)
2014 (673)
2013 (475)
2012 (563)
2011 (647)
2010 (527)
Location
Africa (22)
Alabama (6)
Arizona (21)
Asia (2024)
Australia (233)
California (762)
Canada (169)
China (51)
Colorado (42)
Connecticut (60)
Delaware (46)
Europe (4438)
Florida (130)
Georgia (27)
Hawaii (1)
Idaho (1)
Illinois (109)
India (10)
Indiana (82)
Japan (38)
Kansas (4)
Kentucky (4)
Louisiana (7)
Maine (5)
Maryland (91)
Massachusetts (545)
Michigan (27)
Minnesota (32)
Mississippi (1)
Missouri (12)
Montana (3)
Nevada (11)
New Hampshire (7)
New Jersey (570)
New York (254)
North Carolina (149)
Northern California (382)
Ohio (33)
Oregon (2)
Pennsylvania (208)
Rhode Island (4)
South America (34)
South Carolina (1)
Southern California (324)
Tennessee (13)
Texas (124)
United States (3434)
Utah (38)
Virginia (10)
Washington D.C. (10)
Washington State (68)
West Virginia (1)
Wisconsin (5)
36,547 Results for "108".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
D3 Bio Secures $108 Million in Series B Financing to Advance Global Clinical Programs
December 10, 2025
·
2 min read
Press Releases
ImmunoGenesis Receives $10.8 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Accelerate the Clinical Development of IMGS-001 for Patients with Immune-Excluded Tumors with High Unmet Need
December 4, 2025
·
5 min read
Biotech Bay
Day One Announces Sale of Priority Review Voucher for $108 Million
Day One Biopharmaceuticals, a commercial-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, announced it sold its Priority Review Voucher for $108 million to an undisclosed buyer.
May 30, 2024
·
3 min read
Press Releases
Evaxion announces closing of $10.8 million public offering
February 2, 2025
·
4 min read
Press Releases
Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders
April 11, 2025
·
8 min read
Press Releases
Cytonics Announces that Last Patient Completes Last Visit in First-in-Human Phase 1 Clinical Trial for CYT-108 as a Treatment for Osteoarthritis
April 1, 2025
·
6 min read
Press Releases
Cytonics Announces Successful Completion of Phase 1 Study for First Nine Patients in CYT-108 Clinical Trial
January 21, 2025
·
6 min read
Press Releases
Asphyxia Neonatorum Markets Expected to Grow at a CAGR of 10.8% during 2025-2035, Impelled by Advancements in Neuroprotective Therapies
January 24, 2025
·
9 min read
Press Releases
Aravax Completes Recruitment into Phase 2 Study of PVX108, a novel immunotherapy for the Treatment of Peanut Allergy
October 28, 2024
·
3 min read
Deals
Merck Finalizes $10.8B Prometheus Buy
Merck finalized the acquisition of immune-focused Prometheus Biosciences for approximately $10.8 billion, picking up mid-stage ulcerative colitis and Crohn’s asset.
April 17, 2023
·
2 min read
·
Tristan Manalac
1 of 3,655
Next
